Skip to main content
logo
Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.56
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
12.62
+0.06 (0.48%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Benitec Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
431307657933
Market Cap Growth
31.39%369.05%881.17%-29.60%-71.60%294.06%
Enterprise Value
248205521222
Last Close Price
12.5611.706.994.0519.7272.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
---88.98129.85565.78
PB Ratio
2.353.161.3933.043.291.67
P/TBV Ratio
2.353.161.3933.043.291.67

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
---9.9423.51367.04

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.010.010.012.770.280.01
Net Debt / Equity Ratio
-1.00-1.00-1.07-9.49-1.13-0.98
Net Debt / EBITDA Ratio
3.952.322.260.100.181.46
Net Debt / FCF Ratio
9.284.112.580.110.201.50
Asset Turnover
---0.010.010.00
Quick Ratio
56.4354.2610.380.641.6114.46
Current Ratio
56.8254.6710.490.941.9015.05
Return on Equity (ROE)
-29.58%-52.46%-91.68%-1268.61%-159.08%-91.79%
Return on Assets (ROA)
-19.93%-34.39%-49.60%-228.53%-81.59%-51.55%
Return on Capital Employed (ROCE)
-25.40%-42.70%-47.60%-3926.10%-518.90%-67.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-9.63%-12.35%-33.22%-293.13%-192.09%-41.59%
FCF Yield
-4.59%-7.69%-29.91%-269.92%-167.86%-39.10%
Buyback Yield / Dilution
-37.41%-97.17%-1225.17%-188.30%-90.24%-320.63%
SEC Filings: 10-K · 10-Q